Collagen Matrix Acquired by Metalmark Capital

Metalmark Capital, a New York, N.Y.-based private equity firm, had made a majority investment in Oakland, N.J.-based Collagen Matrix Inc., which makes tissue repair and regeneration products. According to Collagen Matrix, Metalmark’s investment in Collagen Matrix will provide the resources, expertise and capital needed to continue to grow its business. As part of the transaction, Collagen Matrix’s management team, including founder and CEO Shu-Tung Li, Ph.D., will remain with the company. Financial terms were not disclosed.

“We are excited about this opportunity to partner with Metalmark Capital,” said Li. “Over the past 17 years, Collagen Matrix has grown into a leading medical technology company with innovation at the heart of our work. Metalmark’s partnership brings a strong knowledge of the sector as well as access to additional capital and resources that will advance the next chapter of our growth and expand our leadership role in tissue repair and regeneration.”

“Under the leadership of Dr. Shu-Tung Li, Collagen Matrix has become an industry leader that designs, develops, manufactures and markets high quality collagen- and mineral-based products, all of which are delivered through exemplary customer service,” said Fazle Husain, managing director at Metalmark Capital. “We look forward to partnering with the Collagen Matrix management team to support the company in raising its existing business and proprietary technology to a higher level of world-class leadership. This investment broadens Metalmark’s presence in medical devices and strengthens our portfolio in healthcare, an important growth area for the firm.”

Collagen Matrix’s first product was a collagen membrane used in oral surgery. Now its portfolio includes more than 30 different medical devices in the oral/maxillofacial surgery, neurosurgery and orthopedic/spine surgery sectors. The company specializes in collagen- and mineral-based extracellular matrices for tissue and organ repair and regeneration.